ES2109495T3 - Tioureas sustituidas utilizadas como agentes quelantes bifuncionales. - Google Patents
Tioureas sustituidas utilizadas como agentes quelantes bifuncionales.Info
- Publication number
- ES2109495T3 ES2109495T3 ES93911594T ES93911594T ES2109495T3 ES 2109495 T3 ES2109495 T3 ES 2109495T3 ES 93911594 T ES93911594 T ES 93911594T ES 93911594 T ES93911594 T ES 93911594T ES 2109495 T3 ES2109495 T3 ES 2109495T3
- Authority
- ES
- Spain
- Prior art keywords
- pct
- chelating agents
- bifunctional chelating
- substituted thioureas
- sec
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/44—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members
- C07D207/444—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5
- C07D207/448—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. maleimide
- C07D207/452—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. maleimide with hydrocarbon radicals, substituted by hetero atoms, directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/082—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being a RGD-containing peptide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C335/04—Derivatives of thiourea
- C07C335/16—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C335/22—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C337/00—Derivatives of thiocarbonic acids containing functional groups covered by groups C07C333/00 or C07C335/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
- C07C337/06—Compounds containing any of the groups, e.g. thiosemicarbazides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
- C07D213/71—Sulfur atoms to which a second hetero atom is attached
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Abstract
LA INVENCION ES RELATIVA A AGENTES DE QUELACION DE FORMULA (I), EN QUE L ES UN ENLAZADOR; D ES UN SOPORTE PARA ALQUILO, SOPORTE PARA ALQUILO CICLICO O GRUPO DE SOPORTE PARA ARILO SUSTITUIDO CON LOS GRUPOS NHCSNHR; Y R ES HIDROGENO O UN SUSTITUYENTE DE FORMULA GENERAL (I) EN LA QUE A = 0 O 1; B = 0-10; C = 0 O 1; SI C = 1, Y = S, O H2; D = 0-2; E = 0-10; Y Z = H, N+(R'')3X-, SO3H, CO2H, OH, H2PO3; EN QUE X OMO UN HALURO O UN ANION ACIDO Y R'' ES UN ALQUILO INFERIOR C1 AC4, USADO PARA ACOPLAR IONES METALICOS A MOLECULAS BIOLOGICAMENTE ACTIVAS. EN PARTICULAR, TIOUREAS SUSTANCIALES PARA QUELAR METALES TALES COMO TECNETIO ESTA PROVISTO QUE PUEDAN SER CONJUGADAS A MOLECULAS DE DESTINO TALES COMO UN ANTICUERPO, UN PEPTIDO O UNA PROTEINA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/866,375 US5326856A (en) | 1992-04-09 | 1992-04-09 | Bifunctional isothiocyanate derived thiocarbonyls as ligands for metal binding |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2109495T3 true ES2109495T3 (es) | 1998-01-16 |
Family
ID=25347475
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES93911594T Expired - Lifetime ES2109495T3 (es) | 1992-04-09 | 1993-04-08 | Tioureas sustituidas utilizadas como agentes quelantes bifuncionales. |
Country Status (8)
Country | Link |
---|---|
US (3) | US5326856A (es) |
EP (1) | EP0635001B1 (es) |
JP (1) | JPH08502240A (es) |
AT (1) | ATE157084T1 (es) |
CA (1) | CA2117770A1 (es) |
DE (1) | DE69313272T2 (es) |
ES (1) | ES2109495T3 (es) |
WO (1) | WO1993021151A1 (es) |
Families Citing this family (97)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5567411A (en) * | 1986-11-10 | 1996-10-22 | State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon | Dendritic amplifier molecules having multiple terminal active groups stemming from a benzyl core group |
US5443815A (en) * | 1991-11-27 | 1995-08-22 | Diatech, Inc. | Technetium-99m labeled peptides for imaging |
US7238340B1 (en) | 1991-11-27 | 2007-07-03 | Cis Bio International | Monoamine, diamide, thiol-containing metal chelating agents |
US5849261A (en) * | 1991-02-08 | 1998-12-15 | Diatide, Inc. | Radiolabeled vasoactive intestinal peptides for diagnosis and therapy |
US5965107A (en) * | 1992-03-13 | 1999-10-12 | Diatide, Inc. | Technetium-99m labeled peptides for imaging |
US5645815A (en) | 1991-02-08 | 1997-07-08 | Diatide, Inc. | Radiolabled compounds for thrombus imaging |
US5783170A (en) * | 1991-11-27 | 1998-07-21 | Diatide, Inc. | Peptide-metal chelate conjugates |
US5326856A (en) * | 1992-04-09 | 1994-07-05 | Cytogen Corporation | Bifunctional isothiocyanate derived thiocarbonyls as ligands for metal binding |
US5508020A (en) * | 1992-06-05 | 1996-04-16 | Diatech, Inc. | Technetium-99M labeled peptides for imaging |
ES2293635T3 (es) * | 1992-11-16 | 2008-03-16 | Centocor Inc. | Metodo para reducir la inmunogenicidad de la region variable de anticuerpos. |
US5879657A (en) * | 1993-03-30 | 1999-03-09 | The Dupont Merck Pharmaceutical Company | Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders |
US5951964A (en) * | 1993-06-04 | 1999-09-14 | Diatide, Inc. | Technetium-99m labeled peptides for imaging |
US5449761A (en) * | 1993-09-28 | 1995-09-12 | Cytogen Corporation | Metal-binding targeted polypeptide constructs |
GB2284208A (en) * | 1993-11-25 | 1995-05-31 | Pna Diagnostics As | Nucleic acid analogues with a chelating functionality for metal ions |
US5670347A (en) | 1994-05-11 | 1997-09-23 | Amba Biosciences Llc | Peptide-mediated gene transfer |
US5942210A (en) * | 1994-11-15 | 1999-08-24 | Cytogen Corporation | Methods for lyoprotecting a macromolecule using tricine |
US6011021A (en) * | 1996-06-17 | 2000-01-04 | Guilford Pharmaceuticals Inc. | Methods of cancer treatment using naaladase inhibitors |
US6309671B1 (en) | 1995-04-14 | 2001-10-30 | Inhale Therapeutic Systems | Stable glassy state powder formulations |
US5795877A (en) * | 1996-12-31 | 1998-08-18 | Guilford Pharmaceuticals Inc. | Inhibitors of NAALADase enzyme activity |
US6025344A (en) * | 1996-06-17 | 2000-02-15 | Guilford Pharmaceuticals Inc. | Certain dioic acid derivatives useful as NAALADase inhibitors |
IL127605A0 (en) | 1996-06-17 | 1999-10-28 | Guilford Pharm Inc | Methods of cancer treatment using naaladase inhibitors |
US6054444A (en) * | 1997-04-24 | 2000-04-25 | Guilford Pharmaceuticals Inc. | Phosphonic acid derivatives |
US6046180A (en) * | 1996-06-17 | 2000-04-04 | Guilford Pharmaceuticals Inc. | NAALADase inhibitors |
US6384022B1 (en) | 1996-06-17 | 2002-05-07 | Guilford Pharmaceuticals Inc. | Prodrugs of NAALAdase inhibitors |
US6025345A (en) * | 1996-06-17 | 2000-02-15 | Guilford Pharmaceuticals Inc. | Inhibitors of NAALADase enzyme activity |
US5863536A (en) * | 1996-12-31 | 1999-01-26 | Guilford Pharmaceuticals Inc. | Phosphoramidate derivatives |
US6071965A (en) * | 1996-06-17 | 2000-06-06 | Guilford Pharmaceuticals Inc. | Phosphinic alkanoic acid derivatives |
US5824662A (en) * | 1996-09-27 | 1998-10-20 | Guilford Pharmaceuticals Inc. | Treatment of global and focal ischemia using naaladase inhibitors |
US6017903A (en) | 1996-09-27 | 2000-01-25 | Guilford Pharmaceuticals Inc. | Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors |
US5962521A (en) | 1997-04-04 | 1999-10-05 | Guilford Pharmaceuticals Inc. | Hydroxamic acid derivatives |
TR199901173T2 (xx) | 1996-09-27 | 1999-07-21 | Guilford Pharmaceuticals, Inc. | Canl�larda glutamat anormalli�inin tedavisi ve n�ronal aktivitenin d�zenlenmesi i�in y�ntemler ve NAALADase bile�imleri. |
US5981209A (en) * | 1997-12-04 | 1999-11-09 | Guilford Pharmaceuticals Inc. | Use of NAALADase activity to identify prostate cancer and benign prostatic hyperplasia |
US6028216A (en) * | 1997-12-31 | 2000-02-22 | Guilford Pharmaceuticals Inc. | Asymmetric syntheses and intermediates for preparing enantiomer-enriched hydroxyphosphinyl derivatives |
US6395718B1 (en) | 1998-07-06 | 2002-05-28 | Guilford Pharmaceuticals Inc. | Pharmaceutical compositions and methods of inhibiting angiogenesis using naaladase inhibitors |
ATE305449T1 (de) | 1998-07-06 | 2005-10-15 | Guilford Pharm Inc | Naaladase-hemmer anwendbar als pharmazeutische verbindungen und zusammensetzungen |
US6265609B1 (en) | 1998-07-06 | 2001-07-24 | Guilford Pharmaceuticals Inc. | Thio-substituted pentanedioic acid derivatives |
US6444657B1 (en) | 1998-12-31 | 2002-09-03 | Guilford Pharmaceuticals Inc. | Methods for treating certain diseases using naaladase inhibitors |
US6313159B1 (en) | 1999-08-20 | 2001-11-06 | Guilford Pharmaceuticals Inc. | Metabotropic glutamate receptor ligand derivatives as naaladase inhibitors |
AU7353300A (en) | 1999-09-08 | 2001-04-10 | Guilford Pharmaceuticals Inc. | Non-peptidic cyclophilin binding compounds and their use |
US20020077435A1 (en) * | 2000-10-09 | 2002-06-20 | Desimone Joseph M. | Methods for preparing polymers in carbon dioxide having reactive functionality |
US7081472B2 (en) | 2000-11-08 | 2006-07-25 | K. U. Leuven Research & Development | Substituted bis-indole derivatives useful as contrast agents, pharmaceutical compositions containing them and intermediates for producing them |
WO2002059080A2 (en) | 2001-01-25 | 2002-08-01 | Guilford Pharmaceuticals Inc. | Trisubstituted carbocyclic cyclophilin binding compounds and their use |
EP2360476B1 (en) | 2002-02-13 | 2017-10-25 | BioMedica Diagnostics Inc. | Methods for selecting treatment regimens and predicting outcomes in cancer patients |
US7144989B2 (en) * | 2002-03-25 | 2006-12-05 | Albert Einstein College Of Medicine Of Yeshiva University | Pegylated non-hypertensive hemoglobins, methods of preparing same, and uses thereof |
US6737524B2 (en) * | 2002-03-25 | 2004-05-18 | Paul K. Smith | Activated polyethylene glycol compounds |
US8445431B2 (en) * | 2004-06-01 | 2013-05-21 | The Ohio State University | Ligands having metal binding ability and targeting properties |
JP2008515876A (ja) * | 2004-10-07 | 2008-05-15 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | イメージング及び治療用のイメージング及び治療のエンドキットにおけるシュタウディンガーライゲーションの使用 |
EP1828780B1 (en) | 2004-12-22 | 2011-11-23 | California Institute Of Technology | Methods for proteomic profiling using non-natural amino acids |
CN101437548A (zh) * | 2005-10-04 | 2009-05-20 | 皇家飞利浦电子股份有限公司 | 成像和治疗中的施陶丁格反应及用于成像和治疗的试剂盒 |
TW200745163A (en) | 2006-02-17 | 2007-12-16 | Syntonix Pharmaceuticals Inc | Peptides that block the binding of IgG to FcRn |
WO2007110811A2 (en) * | 2006-03-28 | 2007-10-04 | Koninklijke Philips Electronics N.V. | Use of the staudinger ligation in in vivo assembly of a biologically active compound |
US7960139B2 (en) | 2007-03-23 | 2011-06-14 | Academia Sinica | Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells |
JP2010535788A (ja) * | 2007-08-09 | 2010-11-25 | シントニックス・ファーマシューティカルズ・インコーポレーテッド | 免疫調節性ペプチド |
GB0807237D0 (en) * | 2008-04-21 | 2008-05-28 | Crown Packaging Technology Inc | Cutting method and apparatus |
ES2624637T3 (es) * | 2008-05-30 | 2017-07-17 | Atotech Deutschland Gmbh | Aditivo de electrogalvanoplastia para la deposición de una aleación de un metal del grupo IB/binaria o ternaria del grupo IB-grupo IIIA/ternaria, cuaternaria o quinaria del grupo IB, el grupo IIIA-grupo VIA |
JP5986745B2 (ja) | 2008-07-15 | 2016-09-06 | アカデミア シニカAcademia Sinica | Ptfe様のアルミニウム・コート・ガラススライド上のグリカンアレイおよび関連する方法 |
US20100048488A1 (en) * | 2008-08-01 | 2010-02-25 | Syntonix Pharmaceuticals, Inc. | Immunomodulatory peptides |
US11377485B2 (en) | 2009-12-02 | 2022-07-05 | Academia Sinica | Methods for modifying human antibodies by glycan engineering |
US10087236B2 (en) | 2009-12-02 | 2018-10-02 | Academia Sinica | Methods for modifying human antibodies by glycan engineering |
US10338069B2 (en) | 2010-04-12 | 2019-07-02 | Academia Sinica | Glycan arrays for high throughput screening of viruses |
JP6063384B2 (ja) | 2010-10-14 | 2017-01-18 | コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. | プレターゲットキット、プレターゲット方法及びその使用試薬 |
CN103328008B (zh) | 2010-12-21 | 2016-02-24 | 皇家飞利浦电子股份有限公司 | 用于从循环清除生物分子的试剂 |
EP2522369A1 (en) | 2011-05-09 | 2012-11-14 | Koninklijke Philips Electronics N.V. | Pretargeting kit, method and agents used therein |
EP2707394A4 (en) | 2011-05-12 | 2015-06-24 | Metallopharm Llc | METALLO-MEDICINES HAVING IMPROVED PHARMACOLOGICAL PROPERTIES, AND METHODS OF MAKING AND USING THEM |
US8933016B2 (en) | 2012-01-18 | 2015-01-13 | MetalloPharm, LLC | Metallodrugs having improved pharmacological properties and methods of manufacture and use thereof |
US10130714B2 (en) | 2012-04-14 | 2018-11-20 | Academia Sinica | Enhanced anti-influenza agents conjugated with anti-inflammatory activity |
CN102702056B (zh) * | 2012-05-31 | 2014-09-24 | 北京师范大学 | 一种一锅法合成取代间苯二异硫氰酸酯的方法、合成的取代间苯二异硫氰酸酯化合物 |
US9914956B2 (en) | 2012-08-18 | 2018-03-13 | Academia Sinica | Cell-permeable probes for identification and imaging of sialidases |
US10086054B2 (en) | 2013-06-26 | 2018-10-02 | Academia Sinica | RM2 antigens and use thereof |
EP3013347B1 (en) | 2013-06-27 | 2019-12-11 | Academia Sinica | Glycan conjugates and use thereof |
CN105682666B (zh) | 2013-09-06 | 2021-06-01 | 中央研究院 | 使用醣脂激活人类iNKT细胞 |
LT3087095T (lt) | 2013-12-24 | 2019-09-10 | Argenx Bvba | Fcrn-antagonistai ir naudojimo būdai |
CN106459920B (zh) | 2014-01-16 | 2020-10-30 | 中央研究院 | 治疗及检测癌症的组合物及方法 |
US10150818B2 (en) | 2014-01-16 | 2018-12-11 | Academia Sinica | Compositions and methods for treatment and detection of cancers |
JP6562942B2 (ja) | 2014-03-27 | 2019-08-28 | アカデミア シニカAcademia Sinica | 反応性標識化合物およびその使用 |
EP4116329A1 (en) | 2014-05-27 | 2023-01-11 | Academia Sinica | Anti-her2 glycoantibodies and uses thereof |
CN106661562A (zh) | 2014-05-27 | 2017-05-10 | 中央研究院 | 得自类杆菌属的岩藻糖苷酶及其用途 |
CA2950415A1 (en) | 2014-05-27 | 2015-12-03 | Academia Sinica | Anti-cd20 glycoantibodies and uses thereof |
US10118969B2 (en) | 2014-05-27 | 2018-11-06 | Academia Sinica | Compositions and methods relating to universal glycoforms for enhanced antibody efficacy |
KR102494193B1 (ko) | 2014-05-28 | 2023-01-31 | 아카데미아 시니카 | 항-tnf-알파 글리코항체 및 이의 용도 |
JP6899321B2 (ja) | 2014-09-08 | 2021-07-07 | アカデミア シニカAcademia Sinica | 糖脂質を使用するヒトiNKT細胞活性化 |
US10495645B2 (en) | 2015-01-16 | 2019-12-03 | Academia Sinica | Cancer markers and methods of use thereof |
US9975965B2 (en) | 2015-01-16 | 2018-05-22 | Academia Sinica | Compositions and methods for treatment and detection of cancers |
KR20170104617A (ko) | 2015-01-24 | 2017-09-15 | 아카데미아 시니카 | 신규한 글리칸 콘주게이트 및 이를 사용하는 방법 |
SG10201908259WA (en) | 2015-03-09 | 2019-10-30 | Argenx Bvba | Methods of reducing serum levels of fc-containing agents using fcrn antagonsits |
CA3016170A1 (en) | 2016-03-08 | 2017-09-14 | Academia Sinica | Methods for modular synthesis of n-glycans and arrays thereof |
UY37341A (es) | 2016-07-22 | 2017-11-30 | Flamel Ireland Ltd | Formulaciones de gamma-hidroxibutirato de liberación modificada con farmacocinética mejorada |
US11602512B1 (en) | 2016-07-22 | 2023-03-14 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
US11504347B1 (en) | 2016-07-22 | 2022-11-22 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
US11602513B1 (en) | 2016-07-22 | 2023-03-14 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
US11986451B1 (en) | 2016-07-22 | 2024-05-21 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
KR102588027B1 (ko) | 2016-08-22 | 2023-10-12 | 초 파마 인크. | 항체, 결합 단편 및 사용 방법 |
CN113473980A (zh) | 2019-03-01 | 2021-10-01 | 弗拉梅尔爱尔兰有限公司 | 在进食状态下具有改善的药代动力学的γ-羟基丁酸酯组合物 |
CN114126647A (zh) | 2019-06-07 | 2022-03-01 | 阿尔金克斯有限公司 | 适用于皮下施用的FcRn抑制剂的药物制剂 |
WO2020256546A1 (en) | 2019-06-17 | 2020-12-24 | Tagworks Pharmaceuticals B.V. | Compounds for fast and efficient click release |
US11779557B1 (en) | 2022-02-07 | 2023-10-10 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
US11583510B1 (en) | 2022-02-07 | 2023-02-21 | Flamel Ireland Limited | Methods of administering gamma hydroxybutyrate formulations after a high-fat meal |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1307250A (en) * | 1970-06-16 | 1973-02-14 | May & Baker Ltd | Benzene derivatives |
US4048326A (en) * | 1970-06-16 | 1977-09-13 | May & Baker Limited | Treatment of helminth infections with substituted 1,2-bis(thioureido)benzene |
US4072696A (en) * | 1973-02-12 | 1978-02-07 | Syntex (U.S.A.) Inc. | 5(6)-Benzene ring substituted benzimidazole-2-carbamate derivatives having anthelmintic activity |
US4086235A (en) * | 1976-04-12 | 1978-04-25 | Syntex (U.S.A.) Inc. | 5 (6)-Benzene ring substituted benzimidazole-2-carbamate derivatives having anthelmintic activity |
US4060636A (en) * | 1976-06-10 | 1977-11-29 | Rohm And Haas Company | Acetyl- and carbalkoxythioureidobenzophenones as anthelmintic agents |
DE3060377D1 (en) * | 1979-08-29 | 1982-07-01 | Nihon Mediphysics Co Ltd | 2-oxopropionaldehyde bis(thiosemicarbazone)derivatives and their production and use |
US4732864A (en) * | 1983-10-06 | 1988-03-22 | E. I. Du Pont De Nemours And Company | Trace-labeled conjugates of metallothionein and target-seeking biologically active molecules |
US4980147A (en) * | 1984-06-25 | 1990-12-25 | University Of Utah Research Foundation | Radiolabeled technetium chelates for use in renal function determinations |
CA1336076C (en) * | 1985-01-14 | 1995-06-27 | Alan R. Fritzberg | Metal radionuclide labeled proteins for diagnosis and therapy |
WO1987004164A1 (en) * | 1986-01-06 | 1987-07-16 | The University Of Melbourne | Technetium-antibody conjugate |
US4732974A (en) * | 1986-03-05 | 1988-03-22 | Mallinckrodt, Inc. | Metal ion labeling of carrier molecules |
ATE66623T1 (de) * | 1986-05-28 | 1991-09-15 | Lohmann Therapie Syst Lts | Fixiersystem zur befestigung von kathetern, kanuelen oder dgl. auf der hautoberflaeche. |
US4861869A (en) * | 1986-05-29 | 1989-08-29 | Mallinckrodt, Inc. | Coupling agents for joining radionuclide metal ions with biologically useful proteins |
DE3728599A1 (de) * | 1986-12-10 | 1988-06-23 | Hoechst Ag | Verfahren zur herstellung einer mit technetium-99m-markierten organspezifischen substanz |
EP0354923B1 (en) * | 1987-04-02 | 1994-06-29 | Centocor, Inc. | Method for labelling antibodies with a metal ion |
AU2068588A (en) * | 1987-08-12 | 1989-02-16 | Immunomedics Inc. | Preparation of radiolabeled conjugates |
US5218128A (en) * | 1988-06-15 | 1993-06-08 | Centocor, Inc. | Bifunctional coupling agents and radionuclide labeled compositions prepared therefrom |
US5101041A (en) * | 1989-04-26 | 1992-03-31 | The Curators Of The University Of Missouri | Triamines and their derivatives as bifunctional chelating agents |
US5078985A (en) * | 1989-08-09 | 1992-01-07 | Rhomed, Incorporated | Radiolabeling antibodies and other proteins with technetium or rhenium by regulated reduction |
US5080884A (en) * | 1989-12-12 | 1992-01-14 | Medi-Physics, Inc. | Hydrocarbylphenyl diaminodithiol radionuclide complexes and their use in imaging |
US5326856A (en) * | 1992-04-09 | 1994-07-05 | Cytogen Corporation | Bifunctional isothiocyanate derived thiocarbonyls as ligands for metal binding |
-
1992
- 1992-04-09 US US07/866,375 patent/US5326856A/en not_active Expired - Lifetime
-
1993
- 1993-04-08 WO PCT/US1993/003208 patent/WO1993021151A1/en active IP Right Grant
- 1993-04-08 ES ES93911594T patent/ES2109495T3/es not_active Expired - Lifetime
- 1993-04-08 JP JP5518423A patent/JPH08502240A/ja active Pending
- 1993-04-08 US US08/204,197 patent/US5585468A/en not_active Expired - Lifetime
- 1993-04-08 CA CA002117770A patent/CA2117770A1/en not_active Abandoned
- 1993-04-08 EP EP93911594A patent/EP0635001B1/en not_active Expired - Lifetime
- 1993-04-08 AT AT93911594T patent/ATE157084T1/de active
- 1993-04-08 DE DE69313272T patent/DE69313272T2/de not_active Expired - Fee Related
-
1994
- 1994-06-30 US US08/268,445 patent/US5527885A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPH08502240A (ja) | 1996-03-12 |
CA2117770A1 (en) | 1993-10-28 |
US5326856A (en) | 1994-07-05 |
US5585468A (en) | 1996-12-17 |
ATE157084T1 (de) | 1997-09-15 |
US5527885A (en) | 1996-06-18 |
EP0635001A1 (en) | 1995-01-25 |
EP0635001B1 (en) | 1997-08-20 |
DE69313272D1 (de) | 1997-09-25 |
WO1993021151A1 (en) | 1993-10-28 |
DE69313272T2 (de) | 1998-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2109495T3 (es) | Tioureas sustituidas utilizadas como agentes quelantes bifuncionales. | |
ATE184203T1 (de) | Technetium-99m-markierte peptide zur bilderzeugung | |
AU7261994A (en) | Hydrazino-type radionuclide chelators having an n3s configuration | |
DE3766157D1 (de) | Kupplungsmittel zum radiomarkieren von proteinen. | |
NO166267C (no) | Konjugat av et maalsoekende biologisk aktivt molekyl og en forbindelse inneholdende spormerkende metall, samt diagnostisk preparat inneholdende konjugatet. | |
DE59508391D1 (de) | Metallkomplexe mit geladenem linker | |
ES2143059T3 (es) | Complejos metalicos hidrofilos. | |
TR199903331T2 (xx) | Farnesil protein transferas engelleyicileri. | |
PT88417A (pt) | Stabilisierte humanprotein-praeparate | |
AU8188987A (en) | Improved metal complex-containing pharmaceutical agents | |
ATE296312T1 (de) | Metalkomplexbildner | |
ATE359825T1 (de) | J-kette und analoge für konjugate zielgerichtet auf epithelzellen | |
DE69807679D1 (de) | Zusammensetzungen aus konjugaten des stabilen, aktiven, menschlichen ob proteins mit der fc kette von immunoglobulinen und damit zusammenhängende verfahren | |
UA65561A (en) | Therapeutic agent for lymphatic tumors | |
ATE178053T1 (de) | N2s2-chelatoren des hydrazino-typs | |
GR3024667T3 (en) | Cosmetical or pharmaceutical compositions comprising deacylated glycerophospholipids for topical use. | |
NZ504291A (en) | Compositions and methods for targeted delivery of factors | |
DE69612056D1 (de) | Terpenderivate (sarcodictyine) als antikrebsmittel | |
NO970141D0 (no) | Konjugater av metallkomplekser og oligonukleotider, midler inneholdende konjugatene, deres anvendelse ved radiodiagnose samt fremgangsmåte for deres fremstilling | |
DE60006587D1 (de) | Makrozyclische liganden für metallpharmazeutika | |
WO1998051792A8 (en) | Fac molecules and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 635001 Country of ref document: ES |